HOLUBIAK MYRON Z 13D and 13G filings for Citius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-18 4:30 pm Purchase | 2019-04-03 | 13D | Citius Pharmaceuticals, Inc. CTXR | HOLUBIAK MYRON Z | 154,584 2.610% | 68,615 (+79.81%) | Filing |